+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Non-Small Cell Lung Cancer (NSCLC) Pipeline Insight, 2024 - Product Thumbnail Image

Non-Small Cell Lung Cancer (NSCLC) Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Gorlin-syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Gorlin-syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Carcinoid Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Carcinoid Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Adrenocortical Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Adrenocortical Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Adenoid Cystic Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Adenoid Cystic Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Advanced Pancreatic Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Pancreatic Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Advanced Recurrent Ovarian Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Recurrent Ovarian Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Thymoma - Pipeline Insight, 2024 - Product Thumbnail Image

Thymoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Brain metastases - Pipeline Insight, 2024 - Product Thumbnail Image

Brain metastases - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 220 Pages
  • Global
From
Richter's Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Richter's Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Metastatic Hepatocellular Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Hepatocellular Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Malignant Glioma - Pipeline Insight, 2024 - Product Thumbnail Image

Malignant Glioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Uveal Melanoma - Pipeline Insight, 2024 - Product Thumbnail Image

Uveal Melanoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 90 Pages
  • Global
From
Small Cell Lung Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Small Cell Lung Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more